Recent Progress of Adenosine Receptor Modulators in the Development of Anticancer Chemotherapeutic Agents.

Marwein, Sarapynbiang; Mishra, Bijayashree; De, Utpal C; Acharya, Pratap C

Marwein, Sarapynbiang; Mishra, Bijayashree; De, Utpal C; Acharya, Pratap C.

Afiliação

Marwein S; Department of Pharmacy, Tripura University (A Central University), Suryamaninagar-799022, Tripura (W), India.
Mishra B; Department of Chemistry, Tripura University (A Central University), Suryamaninagar-799022, Tripura (W), India.
De UC; Department of Chemistry, Tripura University (A Central University), Suryamaninagar-799022, Tripura (W), India.
Acharya PC; Department of Pharmacy, Tripura University (A Central University), Suryamaninagar-799022, Tripura (W), India.

Curr Pharm Des ; 25(26): 2842-2858, 2019.

Article em En | MEDLINE | ID: mdl-31333105

Assuntos

Antineoplásicos/farmacologia; Neoplasias/tratamento farmacológico; Agonistas do Receptor Purinérgico P1/farmacologia; Antagonistas de Receptores Purinérgicos P1/farmacologia; Humanos; Qualidade de Vida; Receptores Purinérgicos P1

Palavras-chave

A2AAR antagonists; A3AR antagonist; A3AR agonists; Adenosine receptors; angiogenesis; anticancer agents; hypoxia; immunomodulation; pro-tumoral and anti-tumoral effects.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Agonistas do Receptor Purinérgico P1 / Antagonistas de Receptores Purinérgicos P1 / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Curr Pharm Des Assunto da revista: FARMACIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google